Endocrine Abstracts

Aim: To evaluate the adipocins content in the blood with IGT.Materials and methods: One hundred and one patients with IGT were examined (86 women and 15 men) middle-aged 62.1±1.2 years old. The control group included 16 patients (eight women and eight men) middle-aged 22.6±0.6 years old. The anthropometric indications (IMB, WC, and WC/TC), HOMA-IR, insulin, CRP, resistin, leptin, and omentin levels were investigated.Resul...

Aim: To evaluate leptin and other adipocins content in the blood with type 2 diabetes.Materials and methods: Eighty six patients with type 2 diabetes were examined (59 women and 27 men) middle-aged 58.6±1.04 years old. The control group included 16 patients (eight women and eight men) middle-aged 22.6±0.6 years old. The HOMA-IR, insulin, adiponectin, resistin, leptin, and omentin levels were investigated.Results: In patie...

BackgroundOral octreotide capsules (OOC; MYCAPSSA®) are approved in the US for individuals with acromegaly who responded to and tolerated treatment with injectable somatostatin receptor ligands (iSRLs). Add-on cabergoline therapy has shown effectiveness in patients previously inadequately controlled with iSRLS.1 The phase 3 MPOWERED trial assessed maintenance of response with OOC compared to iSRLs. Patients receiving OOC and in...